[go: up one dir, main page]

FR2569702B1 - Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation - Google Patents

Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation

Info

Publication number
FR2569702B1
FR2569702B1 FR8508250A FR8508250A FR2569702B1 FR 2569702 B1 FR2569702 B1 FR 2569702B1 FR 8508250 A FR8508250 A FR 8508250A FR 8508250 A FR8508250 A FR 8508250A FR 2569702 B1 FR2569702 B1 FR 2569702B1
Authority
FR
France
Prior art keywords
deschlororebeccamycine
novel
preparation
pharmaceutical composition
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8508250A
Other languages
English (en)
Other versions
FR2569702A1 (fr
Inventor
James A Matson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2569702A1 publication Critical patent/FR2569702A1/fr
Application granted granted Critical
Publication of FR2569702B1 publication Critical patent/FR2569702B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR8508250A 1984-09-04 1985-05-31 Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation Expired FR2569702B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/646,673 US4524145A (en) 1984-09-04 1984-09-04 4'-Deschlororebeccamycin pharmaceutical composition and method of use

Publications (2)

Publication Number Publication Date
FR2569702A1 FR2569702A1 (fr) 1986-03-07
FR2569702B1 true FR2569702B1 (fr) 1988-10-28

Family

ID=24594001

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8508250A Expired FR2569702B1 (fr) 1984-09-04 1985-05-31 Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation

Country Status (11)

Country Link
US (1) US4524145A (fr)
JP (1) JPS61148192A (fr)
CA (1) CA1249235A (fr)
CY (1) CY1584A (fr)
DK (1) DK160280C (fr)
FR (1) FR2569702B1 (fr)
GB (1) GB2164035B (fr)
HK (1) HK22191A (fr)
HU (1) HU193973B (fr)
IT (1) IT1186723B (fr)
SE (1) SE466207B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567143A (en) * 1984-09-04 1986-01-28 Bristol-Myers Company Process for preparing 4'-deschlororebeccamycin
US4743594A (en) * 1984-09-17 1988-05-10 Schering Corporation Antibiotic, antitumor compounds and their use
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ｕｃｎ―０１
US4764510A (en) * 1986-04-11 1988-08-16 Eli Lilly And Company Antibiotic A42125 and process for its production
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US5015578A (en) * 1989-03-23 1991-05-14 Bristol-Myers Squibb Company BMY-41950 antitumor antibiotic
JPH0725787B2 (ja) * 1990-03-06 1995-03-22 ブリストル−マイヤーズ スクイブ カンパニー 臭化物前駆物質物質供給によるレベカマイシン類似体
US5158938A (en) * 1990-03-06 1992-10-27 Bristol-Myers Squibb Company Rebeccamycin
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Rebeccamycin analogs, their production and pharmaceutical compositions containing them
US5344823A (en) * 1990-03-06 1994-09-06 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41219
AU685389B2 (en) * 1992-03-20 1998-01-22 Wellcome Foundation Limited, The Further indole derivatives with antiviral activity
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
WO1994029340A1 (fr) * 1993-06-04 1994-12-22 Taisho Pharmaceutical Co., Ltd. Facteur d'inhibition de la proliferation de cellules tumorales d'origine humaine
USRE37206E1 (en) * 1994-06-13 2001-06-05 Banyu Pharmaceutical Co, Ltd Gene encoding glycosyltransferase and its uses
US7608420B2 (en) * 2003-04-22 2009-10-27 Lonza Ag Process for the recovery of staurosporine from a fermentation broth
JP6401310B2 (ja) 2014-07-07 2018-10-10 ハネウェル・インターナショナル・インコーポレーテッドＨｏｎｅｙｗｅｌｌ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃ． イオンスカベンジャーを有する熱界面材料

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487925A (en) * 1983-01-28 1984-12-11 Bristol-Myers Company Rebeccamycin and process for its preparation

Also Published As

Publication number Publication date
IT8521002A0 (it) 1985-06-04
SE8502135L (sv) 1986-03-05
FR2569702A1 (fr) 1986-03-07
JPS61148192A (ja) 1986-07-05
DK160280C (da) 1991-07-22
GB2164035B (en) 1988-08-17
DK195585A (da) 1986-03-05
DK195585D0 (da) 1985-05-01
HUT39479A (en) 1986-09-29
JPH0362715B2 (fr) 1991-09-26
DK160280B (da) 1991-02-18
SE466207B (sv) 1992-01-13
CA1249235A (fr) 1989-01-24
SE8502135D0 (sv) 1985-05-02
US4524145A (en) 1985-06-18
IT1186723B (it) 1987-12-16
GB2164035A (en) 1986-03-12
GB8512334D0 (en) 1985-06-19
CY1584A (en) 1992-04-03
HU193973B (en) 1987-12-28
HK22191A (en) 1991-04-04

Similar Documents

Publication Publication Date Title
BE890574A (fr) Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant
FR2531087B1 (fr) Nouvelle forme d'ester de cefuroxime, procede pour sa preparation et composition pharmaceutique la contenant
FR2569402B1 (fr) Derives d'acide 3,5-pyridine-dicarboxylique, procede pour leur preparation et composition pharmaceutique les contenant
FR2505835B1 (fr) Nouvelles 1,2-diaminocyclobutene-3,4-diones, leur procede de preparation et composition pharmaceutique les contenant
PT78340B (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
FR2518095B1 (fr) Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant
OA07282A (fr) Composition pharmaceutique lyophilisée contenant de l'interféron procédé pour la préparation et procédé pour sa stabilisation.
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
FR2495154B1 (fr) 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant
FR2569702B1 (fr) Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation
FR2558829B1 (fr) Isomeres de l'hydroxyvitamine d2, composition pharmaceutique et procede de preparation
BE892552A (fr) Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides
FR2567519B1 (fr) Nouvelles isoindolinyl-alcoyl-piperazines, compositions pharmaceutiques les contenant, et leur procede de preparation
FR2600061B1 (fr) Derives d'indole, composition pharmaceutique les contenant et procede pour leur preparation
FR2700956B1 (fr) Composition cosmetique et pharmaceutique et procede pour sa preparation.
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2528425B1 (fr) 1,4-dihydropyridines et composition pharmaceutique les contenant
FR2558828B1 (fr) " 1a,25-dihydroxy-22z-deshydrovitamine d " composition pharmaceutique et procede de preparation
FR2580649B1 (fr) (-) - 1b - ethyl - 1a - hydroxymethyl -1,2,3,4,6,7,12,12ba-octahydroindolo(2,3-a) quinolizine, procede pour la preparer et compositions pharmaceutiques contenant celle-ci
FR2601951B1 (fr) Nouvelles tetrahydrocarbazolones, composition pharmaceutique les contenant et leur procede de preparation
PT77767A (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
FR2585953B1 (fr) Composition pharmaceutique pour l'administration orale contenant de l'ubiquinone et procede
FR2560211B3 (fr) Activateur de composes peroxo, sa composition, procede pour la preparation et l'utilisation de cet activateur
FR2592043B1 (fr) 2-chloro-12-(3-dimethylamino-2-methylpropyl)-12h-dibenzo-(d, g) (1, 3, 6)-dioxazocines optiquement actives, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2513542B1 (fr) Composition d'engrais, procede pour sa preparation et ses utilisations